A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care

被引:91
作者
Moss-Morris, R. [1 ]
McAlpine, L. [2 ]
Didsbury, L. P. [2 ]
Spence, M. J. [3 ]
机构
[1] Univ Southampton, Sch Psychol, Southampton SO17 1BJ, Hants, England
[2] ProCare Psychol Serv, Auckland, New Zealand
[3] Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand
关键词
Cognitive behavioural therapy (CBT); irritable bowel syndrome (IBS); primary care; randomized controlled trial (RCT); self-management; QUALITY-OF-LIFE; DIAGNOSTIC-CRITERIA; ROME-II; IMPAIRMENT; PREVALENCE; SYMPTOMS; IMPACT; WORK;
D O I
10.1017/S0033291709990195
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. Recent guidelines for the treatment of irritable bowel syndrome (IBS) emphasize the need for research to facilitate home-based self-management for these patients in primary care. The aim of the current study was to test the efficacy of a manualized cognitive behavioural therapy (CBT)-based self-management programme for IBS in a pilot randomized controlled trial (RCT). Method. Sixty-four primary-care patients meeting Rome criteria for FBS were randomized into either self-management plus treatment as usual (TAU) (n = 31) or a TAU control condition (n = 33). The self-management condition included a structured 7-week manualized programme that was self-administered in conjunction with a 1-hour face-to-face therapy session and two 1-hour telephone sessions. The primary outcome measures were the Subject's Global Assessment (SGA) of Relief and the Irritable Bowel Syndrome Severity Scoring System (IBS-SSS) assessed at baseline, end of treatment (2 months), and 3 and 6 months post-treatment. Results. Analysis was by intention-to-treat. Twenty-three (76.7%) of the self-management group rated themselves as experiencing symptom relief across all three time periods compared to seven (21.2%) of the TAU controls [odds ratio (OR) 12.2, 95% confidence interval (CI) 3.72-40.1]. At 8 months, 25 (83%) of the self-management group showed a clinically significant change on the IBS-SSS compared to 16 (49%) of the control group (OR 5.3, 95% CI 1.64-17.26). Conclusions. This study provides preliminary evidence that CBT-based self-management in the form of a structured manual and minimal therapist contact is an effective and acceptable form of treatment for primary-care IBS patients.
引用
收藏
页码:85 / 94
页数:10
相关论文
共 30 条
[1]   Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting [J].
Akehurst, RL ;
Brazier, JE ;
Mathers, N ;
O'Keefe, C ;
Kaltenthaler, E ;
Morgan, A ;
Platts, M ;
Walters, SJ .
PHARMACOECONOMICS, 2002, 20 (07) :455-462
[2]  
Blanchard E.B., 2001, IRRITABLE BOWEL SYND
[3]  
Boyce PM, 2000, AM J GASTROENTEROL, V95, P3176
[4]   A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome [J].
Boyce, PM ;
Talley, NJ ;
Balaam, B ;
Koloski, NA ;
Truman, G .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (10) :2209-2218
[5]  
Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7
[6]  
Dean BB, 2005, AM J MANAG CARE, V11, pS17
[7]   Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders [J].
Drossman, DA ;
Toner, BB ;
Whitehead, WE ;
Diamant, NE ;
Dalton, CB ;
Duncan, S ;
Emmott, S ;
Proffitt, V ;
Akman, D ;
Frusciante, K ;
Le, T ;
Meyer, K ;
Bradshaw, B ;
Mikula, K ;
Morris, CB ;
Blackman, CJ ;
Hu, YM ;
Jia, HG ;
Li, JZ ;
Koch, GG ;
Bangdiwala, SI .
GASTROENTEROLOGY, 2003, 125 (01) :19-31
[8]   Prevalence of gastrointestinal diseases in two British national birth cohorts [J].
Ehlin, AGC ;
Montgomery, SM ;
Ekbom, A ;
Pounder, RE ;
Wakefield, AJ .
GUT, 2003, 52 (08) :1117-1121
[9]   The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress [J].
Francis, CY ;
Morris, J ;
Whorwell, PJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) :395-402
[10]  
Hellier M, 2006, CARE PATIENTS GASTRO